Enhanced CRAd activity using enhancer motifs driven by a nucleosome positioning sequence

Molecular Therapy

Volumn 21, Issue 7, 2013, Pages 1403-1412

  Bravo, Soraya ^a   Núñez, Felipe ^b   Cruzat, Fernando ^c   Cafferata, Eduardo G ^b   De Ferrari, Giancarlo V ^a   Montecino, Martín ^a   Podhajcer, Osvaldo L ^b  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^c UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CONDITIONALLY REPLICATING ADENOVIRUS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DNA MODIFICATION; ENHANCER REGION; FEMALE; GENE DELETION; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOSOME POSITIONING SEQUENCE; ONCOLYTIC VIROTHERAPY; PANCREAS CANCER; PROMOTER REGION; PROTEIN MOTIF; REG1A PROMOTER; TRANSCRIPTION REGULATION; TUMOR CELL DESTRUCTION; TUMOR SPECIFIC PROMOTER; TUMOR XENOGRAFT; VIRUS REPLICATION; WNT RESPONSIVE MOTIF;

EID: 84879687160     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.93     Document Type: Article

References (46)

1. Sutter, AP and Fechner, H (2006). Gene therapy for gastric cancer: is it promising? World J Gastroenterol 12: 380-387. (Pubitemid 43329253)
2. Cathcart, M, O'Byrne, K, Reynolds, J, Sullivan, J and Pidgeon, G (2012). COX-derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention. Biochim Biophys Acta 1825: 49-63.
3. Yang, X, Takano, Y and Zheng, HC (2012). The pathobiological features of gastrointestinal cancers (Review). Oncol Lett 3: 961-969.
4. Herszényi, L and Tulassay, Z (2010). Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14: 249-258.
5. Bhattacharyya, M and Lemoine, NR (2006). Gene therapy developments for pancreatic cancer. Best Pract Res Clin Gastroenterol 20: 285-298.
6. Watanabe, M, Baba, H, Ishioka, C, Nishimura, Y and Muto, M (2012). Recent advances in diagnosis and treatment for malignancies of the gastrointestinal tract. Digestion 85: 95-98.
7. Jørgensen, JT and Hersom, M (2012). HER2 as a Prognostic Marker in Gastric Cancer-A Systematic Analysis of Data from the Literature. J Cancer 3: 137-144.
8. Yamamoto, M (2004). Conditionally replicative adenovirus for gastrointestinal cancers. Expert Opin Biol Ther 4: 1241-1250. (Pubitemid 39005731)
9. Yamamoto, M and Curiel, DT (2010). Current issues and future directions of oncolytic adenoviruses. Mol Ther 18: 243-250.
10. Green, N and Seymour, L (2002). Adenoviral vectors: Systemic delivery and tumor targeting. Cancer Gene Ther 9: 1036-1042. (Pubitemid 35462565)
11. Reid, T, Galanis, E, Abbruzzese, J, Sze, D, Andrews, J, Romel, L et al. (2001). Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Ther 8: 1618-1626. (Pubitemid 33085583)
12. Reid, T, Galanis, E, Abbruzzese, J, Sze, D, Wein, LM, Andrews, J et al. (2002). Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints. Cancer Res 62: 6070-6079. (Pubitemid 35244455)
13. Mulvihill, S, Warren, R, Venook, A, Adler, A, Randlev, B, Heise, C et al. (2001). Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther 8: 308-315. (Pubitemid 32237064)
14. Hecht, JR, Bedford, R, Abbruzzese, JL, Lahoti, S, Reid, TR, Soetikno, RM et al. (2003). A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 9: 555-561. (Pubitemid 36182584)
15. Saukkonen, K and Hemminki, A (2004). Tissue-specifc promoters for cancer gene therapy. Expert Opin Biol Ther 4: 683-696. (Pubitemid 38667814)
16. Krasnykh, VN, Mikheeva, GV, Douglas, JT and Curiel, DT (1996). Generation of recombinant adenovirus vectors with modifed fbers for altering viral tropism. J Virol 70: 6839-6846. (Pubitemid 26307395)
17. Wu, H and Curiel, DT (2008). Fiber-modifed adenoviruses for targeted gene therapy. Methods Mol Biol 434: 113-132.
18. Bai, L and Morozov, AV (2010). Gene regulation by nucleosome positioning. Trends Genet 26: 476-483.
19. Montecino, M, Stein, JL, Stein, GS, Lian, JB, van Wijnen, AJ, Cruzat, F et al. (2007). Nucleosome organization and targeting of SWI/SNF chromatin-remodeling complexes: contributions of the DNA sequence. Biochem Cell Biol 85: 419-425. (Pubitemid 47518037)
20. Gutiérrez, J, Sierra, J, Medina, R, Puchi, M, Imschenetzky, M, van Wijnen, A et al. (2000). Interaction of CBF alpha/AML/PEBP2 alpha transcription factors with nucleosomes containing promoter sequences requires fexibility in the translational positioning of the histone octamer and exposure of the CBF alpha site. Biochemistry 39: 13565-13574.
21. Gutiérrez, J, Paredes, R, Cruzat, F, Hill, DA, van Wijnen, AJ, Lian, JB et al. (2007). Chromatin remodeling by SWI/SNF results in nucleosome mobilization to preferential positions in the rat osteocalcin gene promoter. J Biol Chem 282: 9445-9457. (Pubitemid 47104568)
22. Villagra, A, Cruzat, F, Carvallo, L, Paredes, R, Olate, J, van Wijnen, AJ et al. (2006). Chromatin remodeling and transcriptional activity of the bone-specifc osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity. J Biol Chem 281: 22695-22706.
23. Moon, RT, Kohn, A, De Ferrari, GV and Kaykas, A (2004). Wnt and β-catenin signaling: diseases and therapies. Nature Rev 5: 689-699.
24. Kolligs, FT, Bommer, G and Göke, B (2002). Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66: 131-144. (Pubitemid 36091845)
25. Korinek, V, Barker, N, Morin, PJ, van Wichen, D, de Weger, R, Kinzler, KW et al. (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 275: 1784-1787. (Pubitemid 27136714)
26. Yu, J, Zhang, L, Hwang, PM, Kinzler, KW and Vogelstein, B (2001). PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673-682. (Pubitemid 32706358)
27. Malerba, M, Nikolova, D, Cornelis, J and Iggo, R (2006). Targeting of autonomous parvoviruses to colon cancer by insertion of Tcf sites in the P4 promoter. Cancer Gene Ther 13: 273-280. (Pubitemid 43255764)
28. Kuroda, T, Rabkin, SD and Martuza, RL (2006). Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector. Cancer Res 66: 10127-10135. (Pubitemid 44672067)
29. Liu, X, Qian, Q, Xu, P, Wolf, F, Zhang, J, Zhang, D et al. (2011). A novel conditionally replicating "armed" adenovirus selectively targeting gastrointestinal tumors with aberrant wnt signaling. Hum Gene Ther 22: 427-437.
30. Nuñez, F, Bravo, S, Cruzat, F, Montecino, M and De Ferrari, GV (2011). Wnt/β-catenin signaling enhances cyclooxygenase-2(COX2) transcriptional activity in gastric cancer cells. PLoS ONE 6: e18562.
31. Fukui, H, Fujii, S, Takeda, J, Kayahara, T, Sekikawa, A, Nanakin, A et al. (2003). Expression of Reg 1α protein in human gastric cancers. Digestion 69: 177-184.
32. Tanaka, H, Fukui, H, Fujii, S, Sekikawa, A, Yamagishi, H, Ichikawa, K et al. (2011). Immunohistochemical analysis of REG Ia expression in ulcerative colitis-associated neoplastic lesions. Digestion 83: 204-209.
33. Zhou, L, Zhang, R, Wang, L, Shen, S, Okamoto, H, Sugawara, A et al. (2010). Upregulation of REG Ialpha accelerates tumor progression in pancreatic cancer with diabetes. Int J Cancer 127: 1795-1803.
34. Cafferata, E, Maccio, D, Lopez, M, Viale, D, Carbone, C, Mazzolini, G et al. (2009). A novel A33 promoter based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models. Clin Cancer Res 15: 2037-2049.
35. Viale, DL, Cafferata, EG, Gould, D, Rotondaro, C, Chernajovsky, Y, Curiel, DT et al. (2013). Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to melanoma microenvironment. J Invest Dermatol (in press).
36. Sakakibara, Y, Irie, T, Suzuki, Y, Yamashita, R, Wakaguri, H, Kanai, A et al. (2007). Intrinsic promoter activities of primary DNA sequences in the human genome. DNA Res 14: 71-77.
37. Stein, GS, van Wijnen, AJ, Imbalzano, AN, Montecino, M, Zaidi, SK, Lian, JB et al. (2010). Architectural genetic and epigenetic control of regulatory networks: compartmentalizing machinery for transcription and chromatin remodeling in nuclear microenvironments. Crit Rev Eukaryot Gene Expr 20: 149-155.
38. Vane, JR, Bakhle, YS and Botting, RM (1998). Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120. (Pubitemid 28231490)
39. Modlich, U, Pugh, CW and Bicknell, R (2000). Increasing endothelial cell specifc expression by the use of heterologous hypoxic and cytokine-inducible enhancers. Gene Ther 7: 896-902. (Pubitemid 30303587)
40. Policastro, LL, Ibañez, IL, Durán, HA, Soria, G, Gottifredi, V and Podhajcer, OL (2009). Suppression of cancer growth by nonviral gene therapy based on a novel reactive oxygen species-responsive promoter. Mol Ther 17: 1355-1364.
41. Zaretsky, JZ, Barnea, I, Aylon, Y, Gorivodsky, M, Wreschner, DH and Keydar, I (2006). MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression. Mol Cancer 5: 57.
42. Lee, CY, Bu, LX, DeBenedetti, A, Williams, BJ, Rennie, PS and Jia, WW (2010). Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumors. Mol Ther 18: 929-935.
43. Yochum, GS (2011). Multiple Wnt/ß-catenin responsive enhancers align with the MYC promoter through long-range chromatin loops. PLoS ONE 6: e18966.
44. Morin, PJ, Sparks, AB, Korinek, V, Barker, N, Clevers, H, Vogelstein, B et al. (1997). Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790. (Pubitemid 27136715)
45. Lopez, MV, Rivera, AA, Viale, DL, Benedetti, L, Cuneo, N, Kimball, KJ et al. (2012). A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in mice. Mol Ther 20: 2222-2233.
46. Paredes, R, Arriagada, G, Cruzat, F, Villagra, A, Olate, J, Zaidi, K et al. (2004). Bone-specifc transcription factor Runx2 interacts with the 1alpha, 25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 24: 8847-8861. (Pubitemid 39313891)